Abstract
AbstractEmerging drug resistance and high-attrition rates in early and late stage drug development necessitate accelerated development of antimalarial compounds. However, systematic and meaningful translation of drug efficacy and host-parasite dynamics between preclinical testing stages is missing. We developed an ensemble of mathematical within-host parasite growth and antimalarial action models, fitted to extensive data from four antimalarials with different modes of action, to assess host-parasite interactions in two preclinical drug testing systems of murine parasite P. berghei in mice, and human parasite P. falciparum in immune-deficient mice. We find properties of the host-parasite system, namely resource availability, parasite maturation and virulence, drive P. berghei dynamics and drug efficacy, whereas experimental constraints primarily influence P. falciparum infection and drug efficacy. Furthermore, uninvestigated parasite behavior such as dormancy influences parasite recrudescence following non-curative treatment and requires further investigation. Taken together, host-parasite interactions should be considered for meaningful translation of pharmacodynamic properties between murine systems and for predicting human efficacious treatment.
Funder
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. World Health Organization. (2018) World malaria report 2018. World Helath Organization. https://apps.who.int/iris/handle/10665/275867. License: CC BY-NC-SA 3.0 IGO
2. Tanner, M. et al. Malaria eradication and elimination: views on how to translate a vision into reality. BMC Med. 13, 167, https://doi.org/10.1186/s12916-015-0384-6 (2015).
3. World Health Organization. (2017). Artemisinin and artemisinin-based combination therapy resistance: status report. World Health Organization. https://apps.who.int/iris/handle/10665/255213. License: CC BY-NC-SA 3.0 IGO
4. Wells, T. N., Hooft van Huijsduijnen, R. & Van Voorhis, W. C. Malaria medicines: a glass half full? Nat. Rev. Drug. Discov. 14, 424–442, https://doi.org/10.1038/nrd4573 (2015).
5. Burrows, J. N. et al. New developments in anti-malarial target candidate and product profiles. Malar. J. 16, 26, https://doi.org/10.1186/s12936-016-1675-x (2017).
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献